<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - ANGIOTENSIN-CONVERTING ENZYME INHIBITORS</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drugClass/">Drug classes</a></li>
      </ul>

      <h1>ANGIOTENSIN-CONVERTING ENZYME INHIBITORS</h1>

      <nav>
        <ul class="nav nav-list">

          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#allergyAndCrossSensitivity" data-toggle="tab">Allergy and cross sensitivity</a></li>
          <li><a href="#drugsInClass" data-toggle="tab">Drugs in class</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>ACE inhibitors should be avoided in pregnancy unless essential. They may adversely affect fetal and neonatal blood pressure control and renal function; skull defects and oligohydramnios have also been reported.</p>
            </section>
      </section>


      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

            <section class="doseAdjustments">
              <p>Use with caution, starting with low dose, and adjust according to response. Hyperkalaemia and other side-effects of ACE inhibitors are more common in those with impaired renal function and the dose may need to be reduced.</p>
            </section>
        
      </section>

      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

          <ul>
            <li>The combination of an ACE inhibitor with aliskiren is contra-indicated in patients with an eGFR less than 60&#8239;mL/minute/1.73&#8239;m<sup>2</sup></li>
            <li>the combination of an ACE inhibitor with aliskiren is contra-indicated in patients with diabetes mellitus</li>
          </ul>
      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>notKnown:</strong> Pruritus, abdominal pain, altered liver function tests, angioedema (onset may be delayed; higher incidence reported in Afro-Caribbean patients), arthralgia, blood disorders, bronchospasm, cholestatic jaundice, constipation, diarrhoea, dizziness, dyspepsia, eosinophilia, fatigue, fever, fulminant hepatic necrosis, haemolytic anaemia, headache, hepatic failure, hepatitis, hyperkalaemia, hypoglycaemia, leucocytosis, leucopenia, malaise, myalgia, nausea, neutropenia, pancreatitis, paraesthesia, persistent dry cough, photosensitivity, positive antinuclear antibody, profound hypotension, raised erythrocyte sedimentation rate, rash, renal impairment, rhinitis, serositis, sinusitis, sore throat, taste disturbance, thrombocytopenia, urticaria, vasculitis, vomiting,
              </p>
        
        
            <section class="advice">
                <h3>Hepatic effects</h3>
              <p>In light of reports of cholestatic jaundice, hepatitis, fulminant hepatic necrosis, and hepatic failure, ACE inhibitors should be discontinued if marked elevation of hepatic enzymes or jaundice occur.</p>
            </section>
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <p>For hypertension the first dose should preferably be given at bedtime.</p>
            </section>
      </section>




      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
            Afro-Caribbean patients (may respond less well to ACE inhibitors)
          </li>
          <li>
            concomitant diuretics
          </li>
          <li>
            first dose hypotension (especially in patients taking high doses of diuretics, on a low-sodium diet, on dialysis, dehydrated, or with heart failure)
          </li>
          <li>
            peripheral vascular disease or generalised atherosclerosis (risk of clinically silent renovascular disease)
          </li>
          <li>
            primary aldosteronism (patients may respond less well to ACE inhibitors)
          </li>
          <li>
            the risk of agranulocytosis is possibly increased in collagen vascular disease (blood counts recommended)
          </li>
          <li>
            use with care (or avoid) in those with a history of idiopathic or hereditary angioedema
          </li>
          <li>
            use with care in patients with hypertrophic cardiomyopathy
          </li>
          <li>
            use with care in patients with severe or symptomatic aortic stenosis (risk of hypotension)
          </li>
        </ul>
        <ul>
          <li>
            <p>To prevent anaphylactoid reactions, ACE inhibitors should be avoided during dialysis with high-flux polyacrylonitrile membranes and during low-density lipoprotein apheresis with dextran sulfate; they should also be withheld before desensitisation with wasp or bee venom.</p>
          </li>
        </ul>
      </section>


      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        
            <section class="patientParameters">
              <p>Renal function and electrolytes should be checked before starting ACE inhibitors (or increasing the dose) and monitored during treatment (more frequently if side effects mentioned are present).</p>
            </section>
      </section>










      <section class="tab-pane" id="allergyAndCrossSensitivity">
        <h2>Advice regarding allergies and cross sensitivities</h2>

            <section class="contraindications">
              <p>ACE inhibitors are contra-indicated in patients with hypersensitivity to ACE inhibitors (including angioedema).</p>
            </section>
        
      </section>

      <section class="tab-pane" id="drugsInClass">
        <h2>Drugs in the class of ANGIOTENSIN-CONVERTING ENZYME INHIBITORS</h2>

          <ul>
            <li><a href="../drug/PHP1138.html">CAPTOPRIL</a></li>
            <li><a href="../drug/PHP1150.html">ENALAPRIL MALEATE</a></li>
            <li><a href="../drug/PHP1157.html">FOSINOPRIL SODIUM</a></li>
            <li><a href="../drug/PHP1159.html">IMIDAPRIL HYDROCHLORIDE</a></li>
            <li><a href="../drug/PHP1161.html">LISINOPRIL</a></li>
            <li><a href="../drug/PHP1174.html">MOEXIPRIL HYDROCHLORIDE</a></li>
            <li><a href="../drug/PHP1176.html">PERINDOPRIL ERBUMINE</a></li>
            <li><a href="../drug/PHP1178.html">PERINDOPRIL ARGININE</a></li>
            <li><a href="../drug/PHP1184.html">QUINAPRIL</a></li>
            <li><a href="../drug/PHP1191.html">RAMIPRIL</a></li>
            <li><a href="../drug/PHP1198.html">TRANDOLAPRIL</a></li>
          </ul>
      </section>

    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
</body>
</html>
